Biennial International Congresses
Leading edge meetings of major impact. These are large international meetings held in major cities around the world. They provide a forum for the presentation of the latest findings in neuropsychopharmacology and allow the world’s leading scientists and clinicians to exchange ideas and information. They include plenary lectures, cutting edge scientific symposia, poster sessions and educational and scientific workshops. These are acknowledged to be among the very highest quality scientific programmes in this field. They have delegates from all around the world and an excellent mixture of clinicians and basic scientists from all backgrounds.
Seoul, Republic of Korea 2016 – Following the success of the 30th Congress in Seoul, Korea in July 2016 we now look forward to our 31st Congress which will take place in Vienna, Austria from the 16th – 19th June 2018. For further information on the upcoming Congress, please visit www.cinp.org/vienna
International Thematic Meetings
These are an innovative and exciting new format of CINP meeting which began in 2009. They are international in scope with a mixture of scientific symposia and a significant number of education sessions. They are focused on a single theme and concentrate on specific topics while also incorporating educational and professional development in addition to research sessions. They are expected to be considerably more intimate than the major biennial international congress and provide an optimal environment for the sharing and exchange of knowledge and ideas.
This years Thematic Meeting takes place in Prague, Czech Republic from the 20th – 22nd July 2017. The theme of this meeting is Treatment Resistant Depression. For more information and to register, visit www.cinp.org/prague
The CINP regions organise their own regional meetings, in order to facilitate and stimulate the regional research environment.
The first CINP annual meeting happened in Munich from 13-15 Sept 2012. This meeting took a more informal approach to the meeting formula as indicated by its title Think Tank. There were 7 main discussants whose aim was to advance current thinking on significant problems faced within the field of basic neuropsychopharmacology. The 2nd Think Tank took place in November 2013 and the report from this meeting is available on the 2013 Think Tank page.